Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Hyperplasia and SRD5A1[original query] |
|---|
| A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH. The pharmacogenomics journal 2004 4 (4): 251-9. Klotsman M, Weinberg C R, Davis K, Binnie C G, Hartmann K |
| SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5a-reductase inhibitors and a-adrenergic receptor antagonists. The Journal of urology 2013 Mar . Gu X, Na R, Huang T, Wang L, Tao S, Tian L, Chen Z, Jiao Y, Kang J, Zheng S, Xu J, Sun J, Qi J |
| Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels. International journal of environmental research and public health 2017 Oct 14 (11): . Ry? Aleksandra, Rotter Iwona, Grzywacz Anna, Ma?ecka Iwona, Skonieczna-?ydecka Karolina, Grzesiak Katarzyna, S?ojewski Marcin, Szyli?ska Aleksandra, Sipak-Szmigiel Olimpia, Piasecka Ma?gorzata, Walczakiewicz Kinga, Laszczy?ska Mar |
| Disorders of Sex Development in a Large Ukrainian Cohort: Clinical Diversity and Genetic Findings. Frontiers in endocrinology 2022 4 13 810782. Globa Evgenia, Zelinska Natalia, Shcherbak Yulia, Bignon-Topalovic Joelle, Bashamboo Anu, M?Elreavey K |
- Page last reviewed:Feb 1, 2024
- Content source: